title: Immune reconstitution inflammatory syndrome after withdrawal of natalizumab?
authors.forename: Kerstin
authors.initials: K
authors.lastname: Hellwig
authors.forename: Ralf
authors.initials: R
authors.lastname: Gold
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome / Q000139:chemically induced*; D000069442:Natalizumab; D013375:Substance Withdrawal Syndrome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab